Lexington Hill Partners’s Merck MRK Stock Holding History

Lexington Hill Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$299K	Buy	+2,328	New	+$272K	0.15%	58

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Lexington Hill Partners's MRK Position: Q2 2026 in Review

Lexington Hill Partners opened a new position in Merck (MRK) in Q2 2026: 2,328 shares worth $299K. The stake represents 0.15% of the portfolio and ranks #58 among its holdings.

3,829 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Lexington Hill Partners held 2,328 shares of Merck worth $299K as of Q2 2026.
Merck was a new Lexington Hill Partners position in Q2 2026.
Merck made up 0.15% of Lexington Hill Partners's portfolio in Q2 2026, its #58 holding.
3,829 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Lexington Hill Partners's 13F filing for Q2 2026, filed 8 Jul 2026.